NASDAQ:NEO

Neogenomics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy NEO

*Your capital is at risk

$15.29

-0.590 (-3.72%)

At Close: Jul 31, 2026

NeoGenomics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 79.32. In total, the insiders bought 3.41M and sold 207.46K NEO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	79.32
● Buy	3.41M shares
● Sell	207.46K shares
77% Buy Activity Strong Negative Correlation
Buy Signal High Confidence Mar 02, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 79.32. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (77% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 01, 2026 Buy	Stock Option (Right to Buy) A-Award	Williams Felicia Director	Director	11 069 Value: $116.4K
Jun 01, 2026 Buy	Restricted Stock Unit A-Award	Williams Felicia Director	Director	15 970 Value: $166.7K
Jun 01, 2026 Buy	Common Stock M-Exempt	Williams Felicia Director	Director	23 077 Value: $240.9K
Jun 01, 2026 Buy	Restricted Stock Unit M-Exempt	Kenny John P. Director	Director	5 893 Value: $61.5K
Jun 01, 2026 Buy	Common Stock M-Exempt	Kenny John P. Director	Director	5 893 Value: $61.5K
Jun 01, 2026 Buy	Restricted Stock Unit A-Award	Kenny John P. Director	Director	15 970 Value: $166.7K
Jun 01, 2026 Buy	Stock Option (Right to Buy) A-Award	Kenny John P. Director	Director	11 069 Value: $116.4K
Jun 01, 2026 Buy	Restricted Stock Unit M-Exempt	Kanovsky Stephen M Director	Director	23 077 Value: $240.9K
Jun 01, 2026 Buy	Common Stock M-Exempt	Gunn Neil Director	Director	23 077 Value: $240.9K
Jun 01, 2026 Buy	Restricted Stock Unit A-Award	Gunn Neil Director	Director	15 970 Value: $166.7K
Jun 01, 2026 Buy	Restricted Stock Unit A-Award	Green Marjorie C Director	Director	15 970 Value: $166.7K
Jun 01, 2026 Buy	Restricted Stock Unit M-Exempt	Green Marjorie C Director	Director	22 964 Value: $239.7K
May 11, 2026 Sell	Common Stock F-InKind	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	3 783 Value: $0
May 11, 2026 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	2 559 Value: $0
May 11, 2026 Buy	Common Stock M-Exempt	Olivo Alicia C EVP, GC & Business Development	Officer	3 944 Value: $34.2K
May 11, 2026 Buy	Restricted Stock Unit M-Exempt	Olivo Alicia C EVP, GC & Business Development	Officer	3 944 Value: $34.2K
May 11, 2026 Buy	Common Stock M-Exempt	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	5 830 Value: $50.5K
May 11, 2026 Buy	Restricted Stock Unit M-Exempt	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	5 830 Value: $50.5K
May 02, 2026 Sell	Common Stock F-InKind	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	2 349 Value: $0
May 02, 2026 Sell	Common Stock F-InKind	Aunan Greg D Chief Accounting Officer	Officer	1 309 Value: $0
May 02, 2026 Buy	Common Stock M-Exempt	Aunan Greg D Chief Accounting Officer	Officer	5 372 Value: $82.1K
May 02, 2026 Buy	Restricted Stock Unit M-Exempt	Aunan Greg D Chief Accounting Officer	Officer	5 372 Value: $82.1K
May 02, 2026 Buy	Common Stock M-Exempt	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	5 969 Value: $91.3K
May 02, 2026 Buy	Restricted Stock Unit M-Exempt	Stone Warren Pres & Chief Operating Officer	C-Suite Officer	5 969 Value: $91.3K
May 01, 2026 Sell	Common Stock F-InKind	Olivo Alicia C EVP, GC & Business Development	Officer	1 042 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NEOGENOMICS

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fl...

Read Full Profile Here